Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 12, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 5,753 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 14

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,753 shares

Expires 2023-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option was fully vested and exercisable as of January 12, 2018.

Read SEC document
January 12, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionStock Option (Right to Purchase) · Derivative 1,747 $0.00 Strike: $0.90 $0.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · derivative · entry 13

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64

Underlying: Common Stock · 1,747 shares

Expires 2019-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option was fully vested and exercisable as of January 12, 2018.

Read SEC document
January 12, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 5,753 $21.00 $120,813.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 4

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,164

F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
January 12, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionCommon Stock 5,753 $0.48 $2,761.44
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 3

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 12, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
SaleCommon Stock 1,747 $21.00 $36,687.00
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,164

F2 · kind: The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
January 12, 2018 Filed Mar 3, 2021 20:01 UTC
Fleming Alison BChief Technical Officer
Exercise / conversionCommon Stock 1,747 $0.90 $1,572.30
Disclosure

SEC source: 0001192482-21-000211 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,911

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Certain transactions reported in this Form 4 are late due to an administrative error.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 16:15 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 6,928 $0.00 Strike: $0.48 $0.00
Disclosure

SEC source: 0001192482-18-000037 · edgar.xml · derivative · entry 3

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,753

Underlying: Common Stock · 6,928 shares

Expires 2023-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All of the options were fully vested and exercisable as of January 10, 2018.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 16:15 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 6,928 $19.07 $132,116.96
Disclosure

SEC source: 0001192482-18-000037 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,723

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 10, 2018 Filed Jan 12, 2018 16:15 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 6,928 $0.48 $3,325.44
Disclosure

SEC source: 0001192482-18-000037 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,651

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 14, 2017 Filed Jan 30, 2018 00:38 UTC
Brannelly PaulExecutive Vice President & CFO
GiftCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000063 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,803

Read SEC document
December 08, 2017 Filed Dec 12, 2017 16:20 UTC SaleCommon Stock 19,650 $17.34 $340,731.00
Disclosure

SEC source: 0001209191-17-065191 · doc4.xml · nonDerivative · entry 2

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 45,620

F1 · ownership.nature: This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.

Read SEC document
December 08, 2017 Filed Dec 12, 2017 16:20 UTC SaleCommon Stock 980,350 $17.34 $16,999,269.00
Disclosure

SEC source: 0001209191-17-065191 · doc4.xml · nonDerivative · entry 1

Longitude Capital Partners, LLC · CIK 0001430720 · 10% owner

Tammenoms Bakker Juliet · CIK 0001431159 · 10% owner

ENRIGHT PATRICK G · CIK 0001253886 · 10% owner

Longitude Capital Associates, L.P. · CIK 0001430719 · 10% owner

Longitude Venture Partners L.P. · CIK 0001419701 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By LVP

Disclosed balance after: 2,276,222

F1 · ownership.nature: This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.

Read SEC document
December 08, 2017 Filed Dec 12, 2017 21:23 UTC
Hirsch DavidDirector · 10% owner
SaleCommon Stock 19,650 $17.34 $340,731.00
Disclosure

SEC source: 0001209191-17-065201 · doc4.xml · nonDerivative · entry 2

Hirsch David · CIK 0001619884 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LCA

Disclosed balance after: 45,620

F1 · balance_after: Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities.

F2 · ownership.nature: Reflects securities held by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"). Longitude Capital Partners, LLC ("LCP") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.

Read SEC document
December 08, 2017 Filed Dec 12, 2017 21:23 UTC
Hirsch DavidDirector · 10% owner
SaleCommon Stock 980,350 $17.34 $16,999,269.00
Disclosure

SEC source: 0001209191-17-065201 · doc4.xml · nonDerivative · entry 1

Hirsch David · CIK 0001619884 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By LVP

Disclosed balance after: 2,276,222

F1 · balance_after: Following the transactions reported herein, the reporting person has ceased to be the direct or indirect beneficial owner of more than 10% of any class of the Issuer's equity securities.

F2 · ownership.nature: Reflects securities held by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"). Longitude Capital Partners, LLC ("LCP") is the general partner of LVP and LCA. The reporting person is a member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. The reporting person disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.

Read SEC document
December 05, 2017 Filed Dec 7, 2017 19:03 UTC OtherCommon Stock 800,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-17-000302 · edgar.xml · nonDerivative · entry 1

Skyline Venture Partners V LP · CIK 0001419187 · 10% owner

Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,149,916

F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners.

F2 · balance_after: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC and disclaim beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of their proportionate pecuniary interest therein. Dr. Freund is a director of the Issuer and, accordingly, files separate Section 16 reports.

Read SEC document
December 05, 2017 Filed Dec 8, 2017 00:07 UTC
Freund John GordonDirector · 10% owner
OtherCommon Stock 11,715 $0.00 $0.00
Disclosure

SEC source: 0001192482-17-000306 · edgar.xml · nonDerivative · entry 2

Freund John Gordon · CIK 0001296771 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By John Freund Family Partnership IV, L.P.

Disclosed balance after: 11,715

F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to the reporting person.

F4 · ownership.nature: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.

Read SEC document
December 05, 2017 Filed Dec 8, 2017 00:07 UTC
Freund John GordonDirector · 10% owner
OtherCommon Stock 800,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-17-000306 · edgar.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Skyline Venture Partners V, L.P.

Disclosed balance after: 2,149,916

F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners.

F2 · ownership.nature: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein.

Read SEC document
December 05, 2017 Filed Dec 8, 2017 00:05 UTC OtherCommon Stock 270 $0.00 $0.00
Disclosure

SEC source: 0001192482-17-000304 · edgar.xml · nonDerivative · entry 2

KANEKO YASUNORI · CIK 0001277503 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By the Kaneko Family Trust

Disclosed balance after: 270

F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to the reporting person.

Read SEC document
December 05, 2017 Filed Dec 8, 2017 00:05 UTC OtherCommon Stock 800,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-17-000304 · edgar.xml · nonDerivative · entry 1

KANEKO YASUNORI · CIK 0001277503 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Skyline Venture Partners V, L.P.

Disclosed balance after: 2,149,916

F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners.

F2 · ownership.nature: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Kaneko disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein.

Read SEC document
November 21, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 572 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · derivative · entry 10

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,917

Underlying: Common Stock · 572 shares

Expires 2024-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 2,410 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vests and becomes exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
November 21, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 572 $19.00 $10,868.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 7

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,723

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
November 21, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 572 $0.28 $160.16
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 6

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,295

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 1,239 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · derivative · entry 9

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,489

Underlying: Common Stock · 1,239 shares

Expires 2024-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 2,410 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vests and becomes exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 1,950 $0.00 Strike: $0.28 $0.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · derivative · entry 8

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,225

Underlying: Common Stock · 1,950 shares

Expires 2024-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 2,600 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vests and becomes exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 840 $17.00 $14,280.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 5

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,723

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 1,239 $17.00 $21,063.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 4

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,563

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 1,239 $0.28 $346.92
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 3

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 1,950 $17.00 $33,150.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,563

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
November 17, 2017 Filed Nov 21, 2017 17:41 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 1,950 $0.28 $546.00
Disclosure

SEC source: 0001192482-17-000282 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2017 Filed Nov 18, 2017 02:04 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 50,000 $15.53 $776,500.00
Disclosure

SEC source: 0001192482-17-000277 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 558,987

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016, as amended.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.50 to $15.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 25, 2017 Filed Oct 27, 2017 16:58 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionStock option (right to purchase) · Derivative 1,811 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001192482-17-000263 · edgar.xml · derivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,811 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: All of these options were fully vested and excercisable as of October 25, 2017.

Read SEC document
October 25, 2017 Filed Oct 27, 2017 16:58 UTC
Fleming Alison BChief Technology Officer
Exercise / conversionCommon Stock 1,811 $3.38 $6,121.18
Disclosure

SEC source: 0001192482-17-000263 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2017 Filed Aug 11, 2017 21:37 UTC GrantStock Option (Right to Purchase) · Derivative 25,067 $0.00 Strike: $9.89 $0.00
Disclosure

SEC source: 0001192482-17-000227 · edgar.xml · derivative · entry 1

Melincoff Gwen A · CIK 0001614890 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,067

Underlying: Common Stock · 25,067 shares

Expires 2027-08-09

F1 · derivative.exercise_date: The option vests and becomes exercisable on August 9, 2018, subject to the director's continued service with the issuer.

Read SEC document
August 04, 2017 Filed Aug 4, 2017 16:14 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 200 $12.39 $2,478.00
Disclosure

SEC source: 0001192482-17-000212 · edgar.xml · nonDerivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,752

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 04, 2017 Filed Aug 4, 2017 20:17 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
Tax withholdingCommon Stock 736 $12.39 $9,119.04
Disclosure

SEC source: 0001192482-17-000216 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 608,987

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 04, 2017 Filed Aug 4, 2017 20:15 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 200 $12.39 $2,478.00
Disclosure

SEC source: 0001192482-17-000214 · edgar.xml · nonDerivative · entry 2

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,803

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 28, 2017 Filed Aug 4, 2017 16:14 UTC
Fleming Alison BChief Technology Officer
GrantCommon Stock 639 $10.60 $6,773.40
Disclosure

SEC source: 0001192482-17-000212 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,952

F1 · kind: Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 28, 2017 Filed Aug 4, 2017 20:17 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
GrantCommon Stock 640 $10.60 $6,784.00
Disclosure

SEC source: 0001192482-17-000216 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 609,723

F1 · kind: Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 28, 2017 Filed Aug 4, 2017 20:15 UTC
Brannelly PaulExecutive Vice President & CFO
GrantCommon Stock 776 $10.60 $8,225.60
Disclosure

SEC source: 0001192482-17-000214 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,003

F1 · kind: Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 31, 2017 Filed Jun 2, 2017 20:06 UTC
Ciaffoni JosephChief Operating Officer
GrantStock Option (Right to Purchase) · Derivative 259,283 $0.00 Strike: $8.22 $0.00
Disclosure

SEC source: 0001192482-17-000152 · edgar.xml · derivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,283

Underlying: Common Stock · 259,283 shares

Expires 2027-05-31

F2 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the option vests and becomes exercisable on May 31, 2018, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
May 31, 2017 Filed Jun 2, 2017 20:06 UTC
Ciaffoni JosephChief Operating Officer
GrantCommon Stock 84,268 $0.00 $0.00
Disclosure

SEC source: 0001192482-17-000152 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,268

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on May 31, 2017. Twenty-five percent (25%) of the restricted stock units vest on May 31, 2018, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:23 UTC
Hirsch DavidDirector · 10% owner
GrantStock Option (Right to Purchase) · Derivative 19,853 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0001192482-17-000133 · edgar.xml · derivative · entry 1

Hirsch David · CIK 0001619884 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

Underlying: Common Stock · 19,853 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:35 UTC GrantStock Option (Right to Purchase) · Derivative 19,853 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0001192482-17-000137 · edgar.xml · derivative · entry 1

Schroeder Theodore R · CIK 0001378690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

Underlying: Common Stock · 19,853 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:20 UTC
Freund John GordonDirector · 10% owner
GrantStock Option (Right to Purchase) · Derivative 19,853 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0001192482-17-000131 · edgar.xml · derivative · entry 1

Freund John Gordon · CIK 0001296771 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

Underlying: Common Stock · 19,853 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:44 UTC
SANTINI GINODirector
GrantStock Option (Right to Purchase) · Derivative 19,853 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0001192482-17-000141 · edgar.xml · derivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

Underlying: Common Stock · 19,853 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:42 UTC GrantStock Option (Right to Purchase) · Derivative 19,853 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0001192482-17-000140 · edgar.xml · derivative · entry 1

BOHLIN GAREN G · CIK 0001254705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

Underlying: Common Stock · 19,853 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:33 UTC GrantStock Option (Right to Purchase) · Derivative 19,853 $0.00 Strike: $9.33 $0.00
Disclosure

SEC source: 0001192482-17-000135 · edgar.xml · derivative · entry 1

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

Underlying: Common Stock · 19,853 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2018, subject to the director's continued service with the issuer.

Read SEC document
May 12, 2017 Filed May 15, 2017 21:26 UTC
Brannelly PaulExecutive Vice President & CFO
PurchaseCommon Stock 10,000 $9.18 $91,800.00
Disclosure

SEC source: 0001192482-17-000127 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,227

Read SEC document
March 17, 2017 Filed Mar 21, 2017 16:43 UTC
Duke Barry SSee remarks
Tax withholdingCommon Stock 388 $14.95 $5,800.60
Disclosure

SEC source: 0001192482-17-000086 · edgar.xml · nonDerivative · entry 1

Duke Barry S · CIK 0001640699 · See remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,087

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 16:42 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 388 $14.95 $5,800.60
Disclosure

SEC source: 0001192482-17-000085 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,313

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.